OPPI reinforces commitment to improving health outcomes in India
A new initiative called 'Bharat Ke Liye' (an India-only initiative) has been launched by the Organization of Pharmaceutical Producers of India (OPPI), encapsulating the essence of OPPI’s commitment towards a healthier India by implementing innovative solutions.
The OPPI is an industry group that represents multinational research-based drug companies in India. The organization is to focus on four critical pillars- enabling access, driving innovation, supporting health systems, and committing strategic investments.
Increasing India's healthcare ecosystem and improving the quality of life of its citizens has been a major accomplishment of the global drug industry, notes the OPPI, which adds that the campaign 'Bharat Ke Liye' was born with this as the underlying thought.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze